Baymax - Personal Healthcare Companion Price

Updated 2026-05-07

Baymax is treading water in a tight range, stuck between $0.57 and $0.61 over the last month with no clear directional conviction. The current $0.59 asks sits right at the trough plus 3.5%, which matches the 30-day gain exactly, suggesting mean reversion rather than momentum. This Cold Foil Rare hasn't moved in seven days (0.0% weekly change), a sign of thin liquidity or genuine indifference to the spec at current levels. The 3.3% discount to peak indicates no real pressure to chase, and without a visible demand driver in Lorcana's recent meta or supply shock, this card reads as a bag holder's exit zone rather than an entry point. Watch whether the next 14 days hold the floor at $0.57 or break below it, which would signal that this Cold Foil version lacks the legs to sustain even base Rare pricing in a softer market.